Status:

WITHDRAWN

Impact of a Digital Solution (CardiCare™) on Cardiorespiratory Fitness Improvement in Patients Discharged From a Phase 2 Cardiac Rehabilitation Following an Acute Coronary Syndrome

Lead Sponsor:

Ad scientiam

Conditions:

Acute Coronary Syndrome

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Coronary heart disease is a partial inability of the coronary arteries to supply the heart muscle due to their narrowing. There is angina and myocardial infarction. Coronary heart disease is the first...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Subjects ≥ 18 years old.
  • Diagnosis of an Acute Coronary Syndrome in the last 3 months, documented by angiographically-proven coronary artery disease or hospitalisation report.
  • Graduated from a phase 2 cardiac rehabilitation, ready to enter a phase 3 CR at home.
  • Having agreed to perform a cardiopulmonary exercise testing and blood count at the inclusion or having performed a cardiopulmonary exercise testing and blood count within the last week.
  • Owning a personal smartphone (Android 5.0 or beyond / iPhone 5s and newer supporting IOS 12 and beyond) with Wifi or a data plan (3G/4G).
  • Able to use a smartphone (e.g. no vision, hearing, cognitive or dexterity impairment).
  • Having agreed to install CardiCare™ application on their own smartphone.
  • Having agreed to wear an actigraph at all times and install the actigraph application (CenterPoint Sync) on their smartphone.
  • Enrolled in or benefiting of a national health system.
  • Having read the information sheet and signed the informed consent form.
  • Non-inclusion Criteria:
  • Treated with Coronary Artery Bypass Grafting.
  • Cardiac surgery in the last 12 weeks.
  • Planned revascularisation or surgery in the next 6 months.
  • Clinical heart failure or Left Ventricular Ejection Fraction \< 40% documented within the last 2 months.
  • Severe valvular disease.
  • Severe pulmonary disease.
  • Chronic kidney disease (stages III-V).
  • Drug or/and alcohol abuse (as per clinician's judgment).
  • Unstable angina.
  • Osteoarticular condition or other reasons that limit exercise for more than 4 months (clinician's judgment).
  • Uncontrolled hypertension (resting Diastolic BP\>100 mmHg and resting Systolic BP \>200 mmHg).
  • Severe/uncontrolled arrhythmia.
  • Systemic medical diseases that are likely to affect cognitive functioning.
  • Pregnant women confirmed by a pregnancy test at the inclusion.
  • Participation to another interventional clinical trial (category 1).
  • Illiterate or not proficient in the language of the study country (French, Italian, Spanish or Portuguese according to the country).
  • Person under guardianship or curatorship.

Exclusion

    Key Trial Info

    Start Date :

    December 1 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2023

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT04294940

    Start Date

    December 1 2021

    End Date

    December 1 2023

    Last Update

    June 29 2021

    Active Locations (10)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (10 locations)

    1

    Corentin Celton hospital

    Issy-les-Moulineaux, France

    2

    Lariboisière hospital

    Paris, France

    3

    Saint-Yves clinic

    Rennes, France

    4

    Brie Cardiac Readaptation Centre

    Villeneuve-Saint-Denis, France